Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Odin

Showing results (131-140 of 170) with videos related to

Pageof 17
Sort By:
Movement Disorders Clinical Practice|February 5, 2019
A Pilot Prospective, Multicenter Observational Study of Dopamine Agonist Withdrawal Syndrome in Parkinson's DiseaseKallol Ray Chaudhuri, Antoniya Todorova, Melissa J Nirenberg, et al.
Frontiers in Neurology|August 26, 2021
Advance Care Planning and Care Coordination for People With Parkinson's Disease and Their Family Caregivers-Study Protocol for a Multicentre, Randomized Controlled TrialMarjan J Meinders, Giovanni Gentile, Anette E Schrag, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 8, 2026
Challenges of Pain in Parkinson's Disease: Results from the OCEAN StudyKallol Ray Chaudhuri, Joaquim J Ferreira, Angelo Antonini, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 17, 2025
NLX-112 Randomized Phase 2A Trial: Safety, Tolerability, Anti-Dyskinetic, and Anti-Parkinsonian EfficacyPer Svenningsson, Per Odin, Filip Bergquist, et al.
CNS Drugs|November 22, 2022
Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson's Disease: A Systematic Review and Bayesian Network Meta-analysisAngelo Antonini, Rajesh Pahwa, Per Odin, et al.
Journal of Neurology|January 15, 2025
Impulse control and correlation to dopamine agonist serum concentrations in people with Parkinson's diseaseSara C Staubo, Ole Martin Fuskevåg, Mathias Toft, et al.
European Journal of Neurology|November 13, 2023
Dopamine agonist serum concentrations and impulse control disorders in Parkinson's diseaseSara C Staubo, Ole Martin Fuskevåg, Mathias Toft, et al.
Parkinsonism & Related Disorders|August 10, 2023
Healthcare resource utilization and device-aided therapy discussions with eligible patients across the Parkinson's disease continuum: Revelations from the MANAGE-PD validation cohortHubert H Fernandez, Per Odin, David G Standaert, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 29, 2010
Utility of the WHO-Five Well-being Index as a screening tool for depression in Parkinson's diseaseChristine B Schneider, Maximilian Pilhatsch, Martina Rifati, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 23, 2011
Wearing-off scales in Parkinson's disease: critique and recommendationsAngelo Antonini, Pablo Martinez-Martin, Ray K Chaudhuri, et al.
Pageof 17

Showing results (131-140 of 170) with videos related to

Sort By:
Pageof 17
Movement Disorders Clinical Practice|February 5, 2019
A Pilot Prospective, Multicenter Observational Study of Dopamine Agonist Withdrawal Syndrome in Parkinson's DiseaseKallol Ray Chaudhuri, Antoniya Todorova, Melissa J Nirenberg, et al.
Frontiers in Neurology|August 26, 2021
Advance Care Planning and Care Coordination for People With Parkinson's Disease and Their Family Caregivers-Study Protocol for a Multicentre, Randomized Controlled TrialMarjan J Meinders, Giovanni Gentile, Anette E Schrag, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 8, 2026
Challenges of Pain in Parkinson's Disease: Results from the OCEAN StudyKallol Ray Chaudhuri, Joaquim J Ferreira, Angelo Antonini, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 17, 2025
NLX-112 Randomized Phase 2A Trial: Safety, Tolerability, Anti-Dyskinetic, and Anti-Parkinsonian EfficacyPer Svenningsson, Per Odin, Filip Bergquist, et al.
CNS Drugs|November 22, 2022
Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson's Disease: A Systematic Review and Bayesian Network Meta-analysisAngelo Antonini, Rajesh Pahwa, Per Odin, et al.
Journal of Neurology|January 15, 2025
Impulse control and correlation to dopamine agonist serum concentrations in people with Parkinson's diseaseSara C Staubo, Ole Martin Fuskevåg, Mathias Toft, et al.
European Journal of Neurology|November 13, 2023
Dopamine agonist serum concentrations and impulse control disorders in Parkinson's diseaseSara C Staubo, Ole Martin Fuskevåg, Mathias Toft, et al.
Parkinsonism & Related Disorders|August 10, 2023
Healthcare resource utilization and device-aided therapy discussions with eligible patients across the Parkinson's disease continuum: Revelations from the MANAGE-PD validation cohortHubert H Fernandez, Per Odin, David G Standaert, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 29, 2010
Utility of the WHO-Five Well-being Index as a screening tool for depression in Parkinson's diseaseChristine B Schneider, Maximilian Pilhatsch, Martina Rifati, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 23, 2011
Wearing-off scales in Parkinson's disease: critique and recommendationsAngelo Antonini, Pablo Martinez-Martin, Ray K Chaudhuri, et al.
Pageof 17